Udec S (500+50+10) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Unisolve Pharmaceuticals Pvt Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Paracetamol, Diclofenac Potassium,Serratiopeptidase. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 52 (arround $0.728 US Dollar)
The main active ingredients or salts in Udec S (500+50+10) are :
Serratiopeptidase-10 mg
Paracetamol-500 mg
Diclofenac Potassium-50 mg
Paracetamol Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Diclofenac Potassium Indication (Prescribed for or used as):
For more details on Diclofenac Potassium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Diclofenac Potassium..
Serratiopeptidase Indication (Prescribed for or used as): Anti-Inflammatory agent.
For more details on Serratiopeptidase, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Serratiopeptidase..
Udec S (500+50+10) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 3 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Udec S (500+50+10), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Serratiopeptidase-10 mg Paracetamol-500 mg Diclofenac Potassium-50 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.